DEA Places MDMA-Like Drug Into Schedule I
The Drug Enforcement Administration placed para-methoxymethamphetamine (PMMA), a drug similar to methylenedioxymethamphetamine (MDMA) that is also sold as “ecstasy,” into Schedule I of the Controlled Substances Act, in a final rule released June 24. “This action imposes the regulatory controls…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle PMMA,” DEA said. The final rule takes effect July 26.